Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse

Recruiting Phase 2 Interventional Study
Tobacco Use Tobacco Cessation Insomnia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
114 (estimated)
Sponsor
Yale University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study aims to investigate whether behavioral interventions promote cessation in adult smokers by ameliorating negative emotions and improving self-control and identify the neural markers of these effects.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * English literate * report heavy tobacco use (including nicotine e-cigarettes) for \>6 months * meet biochemical cut off for recent cigarette smoking or e-cigarette use * optimal body mass index Exclusion Criteria: * currently enrolled in other treatments * neuropsychiatric e…
Contacts

Yu Chen, PhD

347-819-2969

yu.chen.yc838@yale.edu

CONTACT

Lisa Fucito, PhD

203-200-1470

lisa.fucito@yale.edu

CONTACT